Skip to content
Congress Index

119th Congress

Menu

119th Congress

H.R. 685 · 119th Congress (2025–2027)

SAVE Moms and Babies Act of 2025

This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.

The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.

The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

Show official title

To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 685’s recorded path, not a universal congressional workflow.

How bills become lawAll actions

  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Robert E. Latta (R-OH-5)
Cosponsors
82 cosponsors

25 original · 57 later

82 R

  1. Rep. Robert B. Aderholt (R-AL-4)· Original · Jan 23, 2025
  2. Rep. Josh Brecheen (R-OK-2)· Original · Jan 23, 2025
  3. Rep. Jake Ellzey (R-TX-6)· Original · Jan 23, 2025
  4. Rep. Randy Feenstra (R-IA-4)· Original · Jan 23, 2025
  5. Rep. Russ Fulcher (R-ID-1)· Original · Jan 23, 2025
  6. Rep. Mike Flood (R-NE-1)· Original · Jan 23, 2025
  7. Rep. Brad Finstad (R-MN-1)· Original · Jan 23, 2025
  8. Rep. Vince Fong (R-CA-20)· Original · Jan 23, 2025
  9. Rep. Michael Guest (R-MS-3)· Original · Jan 23, 2025
  10. Rep. Andy Harris (R-MD-1)· Original · Jan 23, 2025
  11. Rep. Clay Higgins (R-LA-3)· Original · Jan 23, 2025
  12. Rep. Darin LaHood (R-IL-16)· Original · Jan 23, 2025
  13. Rep. Tracey Mann (R-KS-1)· Original · Jan 23, 2025
  14. Rep. John R. Moolenaar (R-MI-2)· Original · Jan 23, 2025
  15. Rep. Mary E. Miller (R-IL-15)· Original · Jan 23, 2025
  16. Rep. Richard McCormick (R-GA-7)· Original · Jan 23, 2025
  17. Rep. Tim Moore (R-NC-14)· Original · Jan 23, 2025
  18. Rep. Andrew Ogles (R-TN-5)· Original · Jan 23, 2025
  19. Rep. Gary J. Palmer (R-AL-6)· Original · Jan 23, 2025
  20. Rep. David Rouzer (R-NC-7)· Original · Jan 23, 2025
  21. Rep. Christopher H. Smith (R-NJ-4)· Original · Jan 23, 2025
  22. Rep. Dale W. Strong (R-AL-5)· Original · Jan 23, 2025
  23. Rep. Jefferson Shreve (R-IN-6)· Original · Jan 23, 2025
  24. Rep. Daniel Webster (R-FL-11)· Original · Jan 23, 2025
  25. Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Jan 23, 2025
  26. Rep. Sheri Biggs (R-SC-3)· Later · Feb 11, 2025
  27. Rep. Scott Fitzgerald (R-WI-5)· Later · Feb 11, 2025
  28. Rep. Barry Moore (R-AL-1)· Later · Sep 19, 2025
  29. Rep. Mike Bost (R-IL-12)· Later · Oct 31, 2025
  30. Rep. Michael Cloud (R-TX-27)· Later · Apr 14, 2026
  31. Rep. Julie Fedorchak (R-ND)· Later · Apr 14, 2026
  32. Rep. Harriet M. Hageman (R-WY)· Later · Apr 14, 2026
  33. Rep. Mike Kelly (R-PA-16)· Later · Apr 14, 2026
  34. Rep. Mike Rogers (R-AL-3)· Later · Apr 14, 2026
  35. Rep. Marlin A. Stutzman (R-IN-3)· Later · Apr 14, 2026
  36. Rep. Glenn Thompson (R-PA-15)· Later · Apr 14, 2026
  37. Rep. Kevin Hern (R-OK-1)· Later · Apr 15, 2026
  38. Rep. Erin Houchin (R-IN-9)· Later · Apr 16, 2026
  39. Rep. Pat Harrigan (R-NC-10)· Later · Apr 16, 2026
  40. Rep. Mike Kennedy (R-UT-3)· Later · Apr 16, 2026
  41. Rep. Ralph Norman (R-SC-5)· Later · Apr 16, 2026
  42. Rep. William R. Timmons IV (R-SC-4)· Later · Apr 16, 2026
  43. Rep. Ben Cline (R-VA-6)· Later · Apr 20, 2026
  44. Rep. Adrian Smith (R-NE-3)· Later · Apr 20, 2026
  45. Rep. Aaron Bean (R-FL-4)· Later · Apr 21, 2026
  46. Rep. Kat Cammack (R-FL-3)· Later · Apr 21, 2026
  47. Rep. Andrew S. Clyde (R-GA-9)· Later · Apr 21, 2026
  48. Rep. Mark B. Messmer (R-IN-8)· Later · Apr 21, 2026
  49. Rep. W. Gregory Steube (R-FL-17)· Later · Apr 21, 2026
  50. Rep. Robert F. Onder, Jr. (R-MO-3)· Later · Apr 22, 2026
  51. Rep. John J. McGuire III (R-VA-5)· Later · Apr 27, 2026
  52. Rep. J. French Hill (R-AR-2)· Later · Apr 28, 2026
  53. Rep. Jeff Crank (R-CO-5)· Later · May 12, 2026
  54. Rep. Joe Wilson (R-SC-2)· Later · May 12, 2026
  55. Rep. Tim Walberg (R-MI-5)· Later · May 13, 2026
  56. Rep. Nicholas A. Langworthy (R-NY-23)· Later · Jun 3, 2026
  57. Rep. Troy Downing (R-MT-2)· Later · Jun 23, 2026
  58. Rep. August Pfluger (R-TX-11)· Later · Jul 13, 2026
  59. Rep. Michelle Fischbach (R-MN-7)· Later · Jul 14, 2026
  60. Rep. Diana Harshbarger (R-TN-1)· Later · Jul 20, 2026
  61. Rep. Claudia Tenney (R-NY-24)· Later · Jul 20, 2026
  62. Rep. Warren Davidson (R-OH-8)· Later · Jul 27, 2026
  63. Rep. Cory Mills (R-FL-7)· Later · Jul 27, 2026
  64. Rep. Jimmy Patronis (R-FL-1)· Later · Aug 6, 2026
  65. Rep. Gus M. Bilirakis (R-FL-12)· Later · Sep 1, 2026
  66. Rep. Brian Babin (R-TX-36)· Later · Sep 1, 2026
  67. Rep. Jack Bergman (R-MI-1)· Later · Sep 1, 2026
  68. Rep. Ron Estes (R-KS-4)· Later · Sep 1, 2026
  69. Rep. Randy Fine (R-FL-6)· Later · Sep 1, 2026
  70. Rep. Paul A. Gosar (R-AZ-9)· Later · Sep 1, 2026
  71. Rep. Craig A. Goldman (R-TX-12)· Later · Sep 1, 2026
  72. Rep. Addison P. McDowell (R-NC-6)· Later · Sep 1, 2026
  73. Rep. Michael K. Simpson (R-ID-2)· Later · Sep 1, 2026
  74. Rep. Andy Biggs (R-AZ-5)· Later · Sep 2, 2026
  75. Rep. H. Morgan Griffith (R-VA-9)· Later · Sep 2, 2026
  76. Rep. Pete Stauber (R-MN-8)· Later · Sep 3, 2026
  77. Rep. Lauren Boebert (R-CO-4)· Later · Sep 4, 2026
  78. Rep. Nathaniel Moran (R-TX-1)· Later · Sep 4, 2026
  79. Rep. James R. Baird (R-IN-4)· Later · Oct 15, 2026
  80. Rep. Gregory F. Murphy (R-NC-3)· Later · Oct 15, 2026
  81. Rep. Darrell Issa (R-CA-48)· Later · Oct 22, 2026
  82. Rep. Rudy Yakym III (R-IN-2)· Later · Oct 22, 2026
Policy area
Health
Subjects
  • Abortion
  • Drug safety, medical device, and laboratory regulation
  • Health information and medical records
  • Health personnel
  • Health technology, devices, supplies
  • Marketing and advertising
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jan 23, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)

  1. SAVE Moms and Babies Act of 2025

    Display title, Short title · Introduced in House

  2. Support And Value Expectant Moms and Babies Act of 2025

    Short title · Introduced in House

  3. To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

    Official title · Introduced in House